Company

Intangles raises $30 mn in funding led by Avataar Venture Partners

Predictive AI start-up Intangles has raised USD 30 million (about Rs 266 crore) in a funding round led by Avataar Venture Partners, the company said on Tuesday. The Pune-based firm received follow-on investments from Baring India Private Equity and Cactus Partners in the funding round. "Intangles, a global leader in physics-enabled Predictive AI...announced the close of its Series B round, securing USD 30 million in growth funding led by Avataar Venture Partners, along with follow-on investments from Baring India Private Equity and Cactus Partners, reaffirming long-term conviction in Intangles' technology platform," the company said in a statement. Intangles claims to have developed the world's first AI platform for vehicles called Inroute. The company said that its digital twin technology makes Intangles the only player globally with the capability to warn fleet owners of impending vehicle failures with the exact causes, up to a month in advance, with around 95 per cent ...

TruAlt Bioenergy shares list nearly 11% above issue price on debut

Shares of biofuels producer TruAlt Bioenergy Ltd on Friday listed with a premium of nearly 11 per cent against the issue price of Rs 496. On the BSE, the stock listed at Rs 550, a jump of 10.88 per cent from the issue price. Shares of the company started trading at Rs 545.40, a premium of 9.95 per cent on the NSE. The company's market valuation stood at Rs 4,617.78 crore. The initial share sale of TruAlt Bioenergy Ltd garnered 71.92 times subscription on the last day of offering on Monday. The company's Rs 839.28 crore IPO had a price band of Rs 472-496 per share. TruAlt's IPO was a combination of a fresh issue of shares worth Rs 750 crore and an offer-for-sale (OFS) of 18 lakh shares valued at Rs 89.28 crore at the upper end, by promoters. Funds raised through the fresh issuance will be earmarked for setting up multi-feed stock operations, payment of debt and general corporate purposes. Bengaluru-based TruAlt Bioenergy is one of the leading biofuels producers and is primarily

Eldeco Infrastructure files draft papers with Sebi for ₹1,000-cr IPO

Real estate developer Eldeco Infrastructure and Properties Ltd has filed preliminary papers with capital markets regulator Sebi to raise Rs 1,000 crore through an initial public offering (IPO). The issue comprises a mix of fresh issues of shares worth Rs 800 crore and an offer for sale up to Rs 200 crore by promoters, according to the draft red herring prospectus (DRHP) dated September 30. The promoters, Pankaj Bajaj and Bandana Kohli, are offering equity shares aggregating up to Rs 102 crore and Rs 98 crore, respectively. The Haryana-based company may consider a pre-IPO placement for up to Rs 160 crore. If such placement is completed, the fresh issue size will be reduced. Proceeds from the fresh issue worth Rs 600 crore will be used for repayment or prepayment of certain outstanding borrowings availed by Eldeco Infracon Realtors Ltd, a subsidiary of the company. The remaining funds will be utilised for general corporate purposes. Eldeco is a real estate developer in north India w

US govt could take stakes in defence companies: Commerce Secretary Lutnick

Following Lutnick's comments, shares of Lockheed were up 1.1%, while Boeing was up about 0.7% and Palantir was down about 1%

Venus Remedies gets GMP renewal certification from Ukraine's SMDC

Pharma major Venus Remedies on Saturday said it has successfully renewed its good manufacturing practices (GMP) certification from Ukraine's State Service on Medicines and Drugs Control (SMDC). The certification applies to the company's Unit-II manufacturing facility located in Baddi, Himachal Pradesh, covering its cephalosporin, non-cephalosporin (carbapenem), and oncology parenteral production lines, including liquid and lyophilized injections, Venus Remedies said in a statement. "Renewal of the Ukrainian GMP certification underlines our unwavering commitment to maintaining world-class manufacturing standards. This milestone not only reinforces our foothold in the Ukrainian market but also facilitates deeper penetration into PIC/S markets, significantly enhancing our international growth prospects," Venus Remedies President, Global Critical Care, Saransh Chaudhary said. Ukraine, being a member of the Pharmaceutical Inspection Co-operation Scheme (PIC/S) consortium, comprising 56 .

Eris Lifesciences Q3FY25 results: Profit skids 18.6%, revenue up 49.6%

This quarter, the organic domestic branded formulations business grew by 12 per cent Y-o-Y, whereas revenue from the branded formulations segment grew by 35 per cent Y-o-Y

eYantra Ventures raises Rs. 15 Crore through preferential issue; eyes global expansion

The company's board of directors approved the equity allotment on 17th January

ABFRL board approves raising $500 mn through preferential issuance and QIP

Fundraise will deleverage company and help in its growth strategy, says fashion retailer

Shareholders approve Gautam Singhania as Raymond Lifestyle chairman

Gautam Hari Singhania has been appointed executive chairman of Raymond Lifestyle Limited, with 86.85% shareholder approval, despite sharp criticism over governance and reputational risks

Fitch revises outlook on 4 Adani firms to 'negative' amid US indictment

The US credit rating agency places three Adani entities under Rating Watch Negative status

Ashoka Buildcon enters share purchase agreement, to sell road assets

The company will also acquire the remaining 34 per cent stake in its unit ACL at an aggregate consideration of Rs 1,526 crore, to make it a wholly owned subsidiary

Is the capitalistic model broken? India needs many more leaders like Tata

Ratan was not the first group head to receive adulation. Archives show when Jamsetji died in 1904, the public was full of praise and love for him

Japan's retail giant Seven & i rejects Couche-Tard's $38.5 bn takeover

Couche-Tard did not immediately respond to a request for comment from Reuters

Rs 2.52 LPA for freshers, how Cognizant hikes salaries for existing employees

IT Giant Cognizant faces backlash over salary hikes. After offering Rs 2.52 lakh per annum to freshers, the US-based company is in the spotlight for its minimal salary hikes.

Q1FY25 results today: Glenmark Pharma among over 400 firms to post earnings

Q1FY25 company results: Cosco India, Bajaj Healthcare, Reliance Infrastructure, and Coffee Day Enterprises will be releasing their quarter results on Aug 14

Cash-flush quick-commerce unicorn Zepto loads up talent cart ahead of IPO

Ahead of its public listing, Zepto plans to ramp up hiring, aiming to add between 400 and 500 employees, focusing on engineering, product, category, growth, and marketing roles

Zomato adds restaurant partner support feature for hiring and registrations

Zomato has teamed up with vendors including Apna, WorkIndia, Shiftz, Rozgaar, and Kaam.com for hiring services

ReNew Energy Global net profit jumps 7-fold to $7 mn in March quarter

ReNew Energy Global Plc on Thursday said its net profit jumped seven-fold to USD 7 million in the January-March quarter of FY24 due to higher income and reduced expenses. The total revenue for the latest fourth quarter decreased by 4.4 per cent to USD 297 million, down from USD 311 million in the same period in the preceding fiscal, according to a company statement. The company attributed the fall in revenue to lower earnings from its transmission projects. The company's net profit for the entire financial year stood at USD 50 million, compared to a net loss of USD 60 million in FY23. The clean energy major registered an 8.1 per cent jump in its total revenue to USD 1,158 million in FY24 from USD 1,072 million in FY23. The company said that the record profits were registered despite a marginal fall in the weighted average Plant Load Factor (PLF) for the reporting quarter as well as the financial year due to lower radiation and wind speeds. While the PLF for FY24 was 26.4 per cent

Paytm Insider announces elevation of Varun Khare to position of COO

Prior to this, Khare was the business head of live entertainment (intellectual properties and partnerships) at the company

Focus on creativity, with games, movies, music, sensors and IP, says Sony

Japanese electronics and entertainment company Sony says it's focusing on creativity in movies, animation and video games, rather than old-fashioned gadgetry. Its chief executive, Kenichiro Yoshida, outlined the company's strategy on Thursday, saying Sony was helping creative professionals deliver what he called kando, or a moving experience. Yoshida did not speak about reports Tokyo-based Sony and Apollo Global Management are interested in buying Paramount Global. Yoshida said the company is now emphasising the creative process itself instead of prized products of the past like the Walkman portable music player and Trinitron colour TVs. He said synergies are no longer between entertainment and electronics, but determined by intellectual property spanning animation, music, games and films. We will continue to support people's creativity through our technology, he said in an online briefing. Sony is adapting to tougher times, with rivals making cheaper but competitive electronics.